- Home
- ATRA vs ZSTK Comparison
ATRA vs ZSTK Comparison
Compare ATRA & ZSTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATRA | ZSTK |
|---|---|---|
| Founded | 2012 | 2019 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.2M | 100.7M |
| IPO Year | 2014 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ATRA | ZSTK |
|---|---|---|
| Price | $9.45 | $4.40 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.67 | N/A |
| AVG Volume (30 Days) | 36.6K | ★ 69.3K |
| Earning Date | 11-11-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 122.52 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $120,772,000.00 | $35,676,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,334.59 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.92 | $1.32 |
| 52 Week High | $19.15 | $12.45 |
Technical Indicators
Market Signals| Indicator | ATRA | ZSTK |
|---|---|---|
| Relative Strength Index (RSI) | 52.74 | 47.93 |
| Support Level | $8.96 | $3.85 |
| Resistance Level | $11.22 | $5.13 |
| Average True Range (ATR) | 0.67 | 0.32 |
| MACD | 0.06 | -0.04 |
| Stochastic Oscillator | 79.08 | 46.22 |
Price Performance
Historical ComparisonAbout ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
About ZSTK ZeroStack Corp. Common Stock
ZeroStack Corp is an AI focused asset management company. The company also operates a world-wide Commercial and wholesale business through its wholly owned subsidiary. ZeroStack is focused on providing exposure to decentralized AI through a concentrated digital asset approach structured to generate yield and fee-based income from staking validators, compute power technology companies, and complementary businesses within the ecosystem and across the wider AI landscape. The other segment commercial and wholesale (Phatebo and TruHC), which sell pharmaceutical products and mix of products across multiple categories including food and beverage, cannabis accessories and technology, personal care and wellness.